Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 29 peer-reviewed journal articles Updated
Immunology · CD70 Deficiency

Active Surveillance and Daily Management

At a Glance

People with CD70 deficiency need long-term, individualized immune support and monitoring, including antibody replacement, vaccine precautions, EBV blood tests, careful dental care, and surveillance for lymphoma and other serious complications.

Managing CD70 deficiency is a marathon of active surveillance and proactive protection. Because the immune system has a specific vulnerability to the Epstein-Barr Virus (EBV), daily life involves a combination of routine therapies to support overall immune function and regular monitoring to detect complications early.

While the diagnosis is rare, the goal of management is to provide a stable, high-quality life while keeping a close eye on the immune system’s vulnerabilities [1][2].

The “Antibody Shield”: Immunoglobulin Replacement

Many patients with CD70 deficiency struggle to produce effective antibodies (immunoglobulins). To compensate, your specialist may prescribe Immunoglobulin Replacement Therapy (IgRT), which provides a concentrated “shield” of antibodies collected from healthy donors to reduce the burden of bacterial infections [3][4].

  • Administration Options: This therapy can be given as an intravenous (IVIG) infusion in a clinic, or as a subcutaneous (SCIG) injection under the skin at home [5][6].
  • Individualized Dosing: The dose and frequency are tailored based on the patient’s weight, infection history, and “trough” levels (the lowest point of antibodies before the next dose) [7][8][9].
  • The Goal: The main aim of IgRT is to prevent recurrent bacterial infections. It is important to know that it is not expected to specifically “clear” EBV [2][10].

Vaccine Safety and Precautions

Because CD70 deficiency is a combined immunodeficiency, the immune system cannot always safely process the weakened viruses found in live vaccines.

  • Avoid Live Vaccines: You should not receive live vaccines (such as BCG, OPV, rotavirus, MMR or Varicella) unless explicitly cleared by your immunologist [11][12]. In severe cases, exposure to a live virus can lead to a serious infection [1][13]. Inactivated vaccines are generally safe, but responses may be reduced.
  • Household Safety: Discuss “herd immunity” with your doctor. Specific guidance is needed for household members receiving live vaccines like rotavirus or nasal influenza, as the risk of “shedding” depends on the vaccine and your clinical status [14][15].

Monitoring EBV Surveillance

For some patients, Epstein-Barr Virus remains in the blood (chronic viremia). Tracking this virus is a cornerstone of long-term care.

  • Serial PCR Testing: Doctors use Quantitative PCR tests to count the “viral load” in the blood [16]. Using the same lab and specimen type (such as whole blood or plasma) for every test is vital so that trends can be tracked accurately [17].
  • Interpreting Results: A rising viral load requires clinical context. One reported patient lived for 15 years with chronic viremia and remained stable into adulthood, though this single case cannot predict individual outcomes [2]. A significant change in viral load may trigger more intense clinical screening for lymphoma or HLH [18].

Dental and Oral Care

A unique feature of CD70 deficiency is a high risk for severe gingivitis and periodontal disease (gum disease) [2].

Research shows that EBV can be detected in the oral cavity, specifically in dental plaque [2]. While it is uncertain if cleaning reduces systemic viral load, poor oral health can lead to bleeding gums and painful ulcers.

  • Daily Maintenance: Meticulous brushing and flossing are essential to reduce the plaque biofilm [19].
  • Professional Cleaning: Regular periodontal assessments and cleanings are necessary. Care should be coordinated between your immunologist and dentist [19][20].

Long-term Surveillance for Malignancy

The most challenging part of living with CD70 deficiency is the substantial risk of developing lymphoproliferative disorders or lymphoma (blood cancer). In a small, combined cohort of CD70 and CD27 deficiency patients, about 43% developed a malignancy, highlighting the significant, though uncertain, risk [21].

  • Physical Exams: Regular clinical check-ups include assessing the neck, armpits, and groin for enlarged lymph nodes, and monitoring for B-symptoms like unexplained fevers and weight loss [22][23].
  • The Transplant Question: Because of the high risk of malignancy and HLH, your team will likely have ongoing discussions about a hematopoietic stem cell transplant (HSCT). This is currently a potentially curative option for the underlying genetic defect, but the decision is individualized and complex [21][24].

Managing the Emotional Burden

Living with a rare EBV-vulnerability syndrome carries a significant psychological weight. The constant cycle of blood tests and clinical monitoring can lead to high levels of anxiety [25][26].

Studies have shown that caregivers of children with PIDs often report lower quality of life and higher rates of depression than the general population [25][27]. Acknowledging this “chronic uncertainty” is a vital part of the care plan. Seeking out peer support groups for rare immunodeficiencies can help navigate the unique stress of this diagnosis [28][29].

Common questions in this guide

Why might I need immunoglobulin replacement for CD70 deficiency?
Immunoglobulin replacement supplies antibodies collected from healthy donors and may reduce recurrent bacterial infections. It can be given through a vein in a clinic or under the skin at home, with dosing based on factors such as weight, infection history, and antibody trough levels. It is not expected to specifically clear EBV.
Which vaccines are unsafe with CD70 deficiency?
Live vaccines such as BCG, oral polio, rotavirus, measles-mumps-rubella, and chickenpox vaccine should be avoided unless an immunologist specifically approves them. Inactivated vaccines are generally safer, but the immune response may be weaker. Household members should ask the care team about live vaccines because the risk from vaccine shedding depends on the vaccine and the patient's condition.
How is EBV monitored over time in CD70 deficiency?
Doctors use a quantitative PCR blood test to measure the amount of EBV in the blood. Using the same laboratory and specimen type, such as whole blood or plasma, makes results easier to compare over time. A rising result is considered alongside symptoms and examination findings and may lead to closer evaluation for lymphoma or a serious inflammatory complication called HLH.
How can I protect my teeth and gums with CD70 deficiency?
Brush carefully and floss every day to reduce plaque, and keep regular dental or periodontal examinations and professional cleanings. Coordinate dental care with the immunologist because CD70 deficiency is linked with severe gum inflammation and periodontal disease. EBV can be found in dental plaque, but it is not known whether cleaning lowers the amount of EBV throughout the body.
What symptoms should prompt a check for lymphoma or other complications?
Tell the care team about newly enlarged lymph nodes in the neck, armpits, or groin, unexplained fevers, or unintentional weight loss. These findings do not by themselves mean cancer, but they may require prompt clinical assessment in someone with CD70 deficiency. A substantial change in EBV levels may also lead to more intensive screening for lymphoma or HLH.
Is a stem cell transplant needed for everyone with CD70 deficiency?
Hematopoietic stem cell transplant can potentially correct the underlying genetic defect, but the decision is individualized rather than automatic. Because the choice is complex and depends on the person's clinical circumstances, it should be discussed in detail with the specialist team.
How can families cope with the stress of long-term monitoring?
Ongoing blood tests and concern about serious complications can cause anxiety for patients and caregivers. Ask the care team about emotional support and peer groups for people living with rare immunodeficiencies. Support can help families manage chronic uncertainty while maintaining daily routines.

Get notified when new evidence is published on EBV-induced lymphoproliferative disease due to CD70 deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (29)
  1. 1

    Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiency.

    Abolhassani H, Edwards ES, Ikinciogullari A, et al.

    The Journal of experimental medicine 2017; (214(1)):91-106 doi:10.1084/jem.20160849.

    PMID: 28011864
  2. 2

    CD70 Deficiency Associated With Chronic Epstein-Barr Virus Infection, Recurrent Airway Infections and Severe Gingivitis in a 24-Year-Old Woman.

    Krüger R, Martin E, Dmytrus J, et al.

    Frontiers in immunology 2020; (11()):1593 doi:10.3389/fimmu.2020.01593.

    PMID: 32849540
  3. 3

    When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach.

    Jolles S, Chapel H, Litzman J

    Clinical and experimental immunology 2017; (188(3)):333-341 doi:10.1111/cei.12915.

    PMID: 28000208
  4. 4

    A clinician's guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases.

    Epland K, Suez D, Paris K

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2022; (18(1)):87 doi:10.1186/s13223-022-00726-7.

    PMID: 36180928
  5. 5

    Impact of IVIG vs. SCIG on IgG trough level and infection incidence in primary immunodeficiency diseases: A systematic review and meta-analysis of clinical studies.

    Shrestha P, Karmacharya P, Wang Z, et al.

    The World Allergy Organization journal 2019; (12(10)):100068 doi:10.1016/j.waojou.2019.100068.

    PMID: 31641401
  6. 6

    Quality of Life Differences for Primary Immunodeficiency Patients on Home SCIG versus IVIG.

    Anterasian C, Duong R, Gruenemeier P, et al.

    Journal of clinical immunology 2019; (39(8)):814-822 doi:10.1007/s10875-019-00705-5.

    PMID: 31673923
  7. 7

    Protective antibody concentrations in primary immunodeficiency following infusion with 5% or 10% intravenous immunoglobulin.

    Paddick M, Clark K, Wolford E, More J

    Allergy and asthma proceedings 2024; (45(6)):414-420 doi:10.2500/aap.2024.45.240033.

    PMID: 39271296
  8. 8

    Immunoglobulin therapies for primary immunodeficiency diseases (part 2): considerations for dosing strategies.

    Li Z, Mahmood I

    Immunotherapy 2024; (16(13)):895-905 doi:10.1080/1750743X.2024.2382074.

    PMID: 39323406
  9. 9

    Immunoglobulin replacement for primary immunodeficiency: Indications for initiating and continuing treatment.

    Wasserman RL

    Allergy and asthma proceedings 2021; (42(6)):489-494 doi:10.2500/aap.2021.42.210082.

    PMID: 34871156
  10. 10

    Immunoglobulin replacement therapies in inborn errors of immunity: a review.

    Sil A, Basu S, Joshi V, et al.

    Frontiers in pediatrics 2024; (12()):1368755 doi:10.3389/fped.2024.1368755.

    PMID: 38425666
  11. 11

    Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians' perspectives in the endgame plan for polio eradication.

    Galal NM, Meshaal S, ElHawary R, et al.

    BMC research notes 2018; (11(1)):717 doi:10.1186/s13104-018-3822-7.

    PMID: 30305145
  12. 12

    Guidelines for Screening, Early Diagnosis and Management of Severe Combined Immunodeficiency (SCID) in India.

    Madkaikar M, Aluri J, Gupta S

    Indian journal of pediatrics 2016; (83(5)):455-62 doi:10.1007/s12098-016-2059-5.

    PMID: 26920398
  13. 13

    Adverse events following immunization in patients with primary immunodeficiencies.

    Sarmiento JD, Villada F, Orrego JC, et al.

    Vaccine 2016; (34(13)):1611-1616 doi:10.1016/j.vaccine.2016.01.047.

    PMID: 26850760
  14. 14

    Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio Eradication.

    Aghamohammadi A, Abolhassani H, Kutukculer N, et al.

    Frontiers in immunology 2017; (8()):685 doi:10.3389/fimmu.2017.00685.

    PMID: 28952612
  15. 15

    Update on Immunodeficiency-Associated Vaccine-Derived Polioviruses - Worldwide, July 2018-December 2019.

    Macklin G, Diop OM, Humayun A, et al.

    MMWR. Morbidity and mortality weekly report 2020; (69(28)):913-917 doi:10.15585/mmwr.mm6928a4.

    PMID: 32673297
  16. 16

    Quantitative PCR for Plasma Epstein-Barr Virus Loads in Cancer Diagnostics.

    Loghavi S

    Methods in molecular biology (Clifton, N.J.) 2016; (1392()):51-61 doi:10.1007/978-1-4939-3360-0_6.

    PMID: 26843046
  17. 17

    Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients.

    Lazzarotto T, Chiereghin A, Piralla A, et al.

    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2018; (24(8)):1699-1706 doi:10.1016/j.bbmt.2018.03.005.

    PMID: 29545186
  18. 18

    When to suspect inborn errors of immunity in Epstein-Barr virus-related lymphoproliferative disorders.

    Sacco KA, Notarangelo LD, Delmonte OM

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2023; (29(4)):457-462 doi:10.1016/j.cmi.2022.10.003.

    PMID: 36209991
  19. 19

    Drug-Induced Gingival Overgrowth Associated With Cyclosporine Therapy: A Case Report of a 23-Year Periodontal Follow-Up in a Heart Transplant Recipient.

    Valente P, Sbrenna L, Valente F, et al.

    Cureus 2025; (17(11)):e97019 doi:10.7759/cureus.97019.

    PMID: 41426737
  20. 20

    Periodontal Disease in Patients Receiving Dialysis.

    Miyata Y, Obata Y, Mochizuki Y, et al.

    International journal of molecular sciences 2019; (20(15)) doi:10.3390/ijms20153805.

    PMID: 31382656
  21. 21

    Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency.

    Ghosh S, Köstel Bal S, Edwards ESJ, et al.

    Blood 2020; (136(23)):2638-2655 doi:10.1182/blood.2020006738.

    PMID: 32603431
  22. 22

    Chronic Active Epstein-Barr Virus Disease.

    Kimura H, Cohen JI

    Frontiers in immunology 2017; (8()):1867 doi:10.3389/fimmu.2017.01867.

    PMID: 29375552
  23. 23

    Acquired immune deficiency syndrome-related intravascular large B-cell lymphoma primarily arising from lymph nodes: a case report.

    Zhang W, Li QS, Deng CG, Yuan J

    Frontiers in oncology 2026; (16()):1767472 doi:10.3389/fonc.2026.1767472.

    PMID: 41695352
  24. 24

    Novel indications for hematopoietic stem cell transplantation in inborn errors of immunity.

    Laberko A, Gennery AR

    Expert review of clinical immunology 2026; (22(2)):183-193 doi:10.1080/1744666X.2026.2641540.

    PMID: 41786511
  25. 25

    Evaluation of Psychiatric Symptomatology, Quality of Life, and Caregiver Burden in Mothers and Children with Primary Immunodeficiency.

    Kılıç N, Kaya Ş, Taşçı G, et al.

    Allergologia et immunopathologia 2023; (51(6)):45-53 doi:10.15586/aei.v51i6.927.

    PMID: 37937495
  26. 26

    Health-Related Quality of Life of Patients and Families with Primary Immunodeficiency in Malaysia: a Cross-Sectional Study.

    Ahmed Meelad R, Abd Hamid IJ, Zainudeen ZT, et al.

    Journal of clinical immunology 2023; (43(5)):999-1006 doi:10.1007/s10875-023-01463-1.

    PMID: 36882668
  27. 27

    Health-Related Quality of Life in Children and Adults with Primary Immunodeficiencies: A Systematic Review and Meta-Analysis.

    Peshko D, Kulbachinskaya E, Korsunskiy I, et al.

    The journal of allergy and clinical immunology. In practice 2019; (7(6)):1929-1957.e5 doi:10.1016/j.jaip.2019.02.013.

    PMID: 30797077
  28. 28

    Shared Decision-Making and Health-Related Quality of Life in the Diagnosis and Management of Patients With Inborn Errors of Immunity.

    Lawrence MG, Kim VHD, Orange JS, Scherzer R

    The journal of allergy and clinical immunology. In practice 2026; doi:10.1016/j.jaip.2026.07.010.

    PMID: 42447994
  29. 29

    Vulnerability beyond infection: Effects of peer victimization on quality of life and psychosocial well-being in inborn errors of immunity.

    Meric Z, Durcan G, Coban ZB, et al.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2026; (37(3)):e70318 doi:10.1111/pai.70318.

    PMID: 41800593

This page is for informational purposes only and does not constitute medical advice about CD70 deficiency. Your immunologist and care team should tailor vaccines, immunoglobulin therapy, EBV testing, and transplant decisions to your situation.

Guide contents EBV-induced lymphoproliferative disease due to CD70 deficiency
Research & Literature
04 The Diagnostic Path 06 Treating Complications